Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidate.
Anthelmintic resistance has become a global phenomenon in gastro-intestinal nematodes of farm animals, including multi-drug resistance against the three major classes of anthelmintics. There is an urgent need for an anthelmintic with a new mode of action. The recently discovered amino-acetonitrile derivatives (AADs) offer a new class of synthetic chemicals with anthelmintic activity. The evaluation of AADs was pursued applying in vitro assays and efficacy and tolerability studies in rodents, sheep, and cattle. Amongst various suitable compounds, AAD 1566 eliminated many tested pathogenic nematode species, both at larval and adult stages, at a dose of 2.5 mg/kg bodyweight in sheep and 5.0 mg/kg bodyweight in cattle. The same doses were sufficient to cure animals infected with resistant or multi-drug-resistant nematode isolates. These findings, complemented by the good tolerability and low toxicity to mammals, suggest that AAD 1566, monepantel, would be a suitable anthelmintic drug development candidate.
Kaminsky
R
R
Novartis Centre de Recherche Santé Animale, CH-1566 St. Aubin, Switzerland. ronald.kaminsky@novartis.com
Gauvry
N
N
Schorderet Weber
S
S
Skripsky
T
T
Bouvier
J
J
Wenger
A
A
Schroeder
F
F
Desaules
Y
Y
Hotz
R
R
Goebel
T
T
Hosking
B C
BC
Pautrat
F
F
Wieland-Berghausen
S
S
Ducray
P
P
D000607:Aminoacetonitrile / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000969:Antinematodal Agents / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology* / Q000633:toxicity; D002417:Cattle; D007814:Larva / Q000187:drug effects; D015394:Molecular Structure; D009348:Nematoda / Q000187:drug effects*; D009349:Nematode Infections / Q000188:drug therapy / Q000662:veterinary*; D012377:Rodentia; D012756:Sheep
D000969:Antinematodal Agents; D000607:Aminoacetonitrile